Funktsionaalsed seened, mis on tuntud ka kui meditsiiniseened, on maailmas enim uuritud seenteklass, mida hinnatakse kõrgelt nende tervist turgutavate toimete tõttu – nt on nad võimsad antioksüdandid ja omavad muuseas ka närvirakke arendavaid, immuunsust tugevdavaid ning põletikku vähendavaid omandusi.
Name
Osaühing Aatinger
Registry code
10636696
VAT number
EE100588736
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.01.2000 (24)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c. 68329 - Other real estate management or related activities
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Marika Vesseluha 02.04.1956 (68) | 100% - 40 000.00 EEK | Board member | Direct ownership | |
Tiina Sokk 06.03.1967 (57) | - | - | - | Founder |
2019 02.06.2021 | 2020 06.06.2023 | 2021 06.06.2023 | 2022 07.09.2023 | |
---|---|---|---|---|
Total Revenue | 9 093 € | 0 € | 32 011 € | 0 € |
Net profit (loss) for the period | 8 414 € | 6 261 € | 31 470 € | 7 051 € |
Profit Margin | 93% | - | 98% | - |
Current Assets | 15 476 € | 17 731 € | 119 532 € | 127 192 € |
Fixed Assets | 61 425 € | 65 431 € | - | - |
Total Assets | 76 901 € | 83 162 € | 119 532 € | 127 192 € |
Current Liabilities | 601 € | 601 € | 5 501 € | 6 110 € |
Non Current Liabilities | 0 € | 0 € | - | - |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | 76 300 € | 82 561 € | 114 031 € | 121 082 € |
Employees | 0 | 0 | 0 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | - | - | - |
2023 Q4 | - | - | - | - |
2023 Q3 | - | - | - | - |
2023 Q2 | - | - | - | - |
2023 Q1 | - | - | - | - |
2022 Q4 | - | - | - | - |
2022 Q3 | - | - | - | - |
2022 Q2 | - | - | - | - |
2022 Q1 | - | - | - | - |
2021 Q4 | 32 011.6 € | 6 402.32 € | - | - |
2021 Q3 | - | - | - | - |
2021 Q2 | - | - | - | - |
2021 Q1 | - | - | - | - |
2020 Q4 | - | - | - | - |
2020 Q3 | - | - | - | - |
2020 Q2 | - | - | - | - |
2020 Q1 | - | - | - | - |